Protein-calorie malnutrition (PCM) can develop both from inadequate food in
take and as a consequence of diseases such as cancer and AIDS. Several stud
ies have shown that PCM can alter drug clearance but little information is
available on the effect of PCM on individual cytochrome P450 isoforms and p
hase II conjugation enzymes. The aim of the present study was to begin a sy
stematic evaluation of the effect of PCM on the activity of individual drug
metabolizing enzymes in a rat model of PCM. Control and PCM rats received
isocaloric diets which contained either 21% or 5% (deficient) protein. Afte
r 3 weeks, the animals were sacrificed and microsomal and cytosolic fractio
ns prepared. Ethoxyresorufin O-deethylation (EROD), chlorzoxazone 6-hydroxy
lation, dextromethorphan N- and O-demethylation and 1-chloro-2,4-dinitroben
zene (CDNB) conjugation were used as measures of CYP1A, CYP2E1, CYP3A2, CYP
2D1 and glutathione S-transferase (GST) activity, respectively. Additionall
y, NADPH-cytochrome P450 reductase activity was measured in the liver micro
somes. PCM significantly reduced the maximum velocity (V-max) of all model
reactions studied. However, differential effects were observed with respect
to K-m values of the reactions. The K-m values for EROD and dextromethorph
an N-demethylation were significantly increased in PCM animals, whereas the
K-m values for chlorzoxazone 6-hydroxylation and dextromethorphan O-demeth
ylation were decreased. In contrast, the K-m value for CDNB conjugation was
unchanged. When NADPH-cytochrome P450 reductase activity was compared, a 2
9% reduction in reductase activity was noted in PCM animals as compared to
controls. Thus, it appears that PCM decreases the overall activity of certa
in phase I and phase II metabolism enzymes in rat liver while exhibiting di
fferential effects on K-m. Furthermore, this reduction in activity may be d
ue in part to diminished activity of cytochrome P450 reductase.